Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanxin Xu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|November 24, 2004
[An improved back-projection algorithm of dynamic electrical impedance tomography]Guanxin Xu, Wei He, H Singer
Journal of Cardiothoracic Surgery|October 21, 2022
The influence of 10-year Nuss bar placement on bar removal: a case reportHaihua Gu, Guanxin Xu, Tianshu Liu, et al.
Oncotargets and Therapy|February 6, 2020
circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3pJie Yao, Guanxin Xu, Ling Zhu, et al.
Molecular Genetics and Genomics : MGG|April 24, 2026
XAF1 nonsense mutation rs117407731 enhances lung adenocarcinoma susceptibility via apoptosis suppressionGuanxin Xu, Hang Zhang, Sai Zhang, et al.
Clinical Science (London, England : 1979)|March 29, 2020
miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathwayJunqiang Fan, Guanxin Xu, Zhibo Chang, et al.
Cancer Reports (Hoboken, N.J.)|June 29, 2023
Anlotinib plus camrelizumab achieved long-term survival in a patient with metastatic esophageal neuroendocrine carcinomaLingxiao Zhou, Guanxin Xu, Tianwei Chen, et al.
Thoracic Cancer|October 15, 2020
Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort studyJie Yao, Erjia Zhu, Ming Li, et al.
Medcomm|April 3, 2026
Dynamic T-Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung CancerRui Jin, Anhao Tian, Weina Lu, et al.
Nature Communications|May 24, 2016
CXXC finger protein 1 is critical for T-cell intrathymic development through regulating H3K4 trimethylationWenqiang Cao, Jing Guo, Xiaofeng Wen, et al.
Nature Communications|December 8, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral bloodYang Xia, Yin Zhu, Sai Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|November 24, 2004
[An improved back-projection algorithm of dynamic electrical impedance tomography]Guanxin Xu, Wei He, H Singer
Journal of Cardiothoracic Surgery|October 21, 2022
The influence of 10-year Nuss bar placement on bar removal: a case reportHaihua Gu, Guanxin Xu, Tianshu Liu, et al.
Oncotargets and Therapy|February 6, 2020
circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3pJie Yao, Guanxin Xu, Ling Zhu, et al.
Molecular Genetics and Genomics : MGG|April 24, 2026
XAF1 nonsense mutation rs117407731 enhances lung adenocarcinoma susceptibility via apoptosis suppressionGuanxin Xu, Hang Zhang, Sai Zhang, et al.
Clinical Science (London, England : 1979)|March 29, 2020
miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathwayJunqiang Fan, Guanxin Xu, Zhibo Chang, et al.
Cancer Reports (Hoboken, N.J.)|June 29, 2023
Anlotinib plus camrelizumab achieved long-term survival in a patient with metastatic esophageal neuroendocrine carcinomaLingxiao Zhou, Guanxin Xu, Tianwei Chen, et al.
Thoracic Cancer|October 15, 2020
Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort studyJie Yao, Erjia Zhu, Ming Li, et al.
Medcomm|April 3, 2026
Dynamic T-Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung CancerRui Jin, Anhao Tian, Weina Lu, et al.
Nature Communications|May 24, 2016
CXXC finger protein 1 is critical for T-cell intrathymic development through regulating H3K4 trimethylationWenqiang Cao, Jing Guo, Xiaofeng Wen, et al.
Nature Communications|December 8, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral bloodYang Xia, Yin Zhu, Sai Zhang, et al.
Pageof 1